3rd International Conference on Pharmaceutical and Pharma Industry (Pharma 2024)

Target Identification & Validation
.Hit-to-Lead Optimization:
Preclinical Development:
Clinical Trial design & Management:
Regulatory Affairs & Market Approval:
Synthesis & Process Chemistry:
Formulation Development:
Quality Control & Assurance:
Continuous Manufacturing & Process Innovation:
Biologics & Biosimilars:
Pharmacokinetics (PK) & Pharmacodynamics (PD)
Drug Interactions & Adverse events:
Special Populations:
Precision Medicine:
Rare Diseases & Orphan Drugs:
Drug Delivery Systems:
Digital Health & AI in Pharma:
3D Printing & Personalized Medicine:
Regenerative Medicine & Cell Therapies:
Nanotechnology & Nano medicine:
Regulatory Science & Policy
Intellectual Property & Patent Law:
Medical Affairs & Scientific Communication:
. Ethical Considerations in Pharma:
Real-World Evidence (RWE) & Post-Market Surveillance:
Drug Repurposing & Drug Combinations:
. Pharmaceutical Microbiology & Sterility Assurance:
Pharmaceutical Packaging & Labeling:
Global Health & Access to Medicines
Case Studies and Reports